We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

3,168.803 days ago
3,349.103 days ago
arrow

LOWER/UPPER CIRCUITS

2,992.60
3,657.60
arrow
Torrent Pharmaceuticals Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 21.68%
Net profit growth 5Y CAGR : 30.59%

STOCK RETURNS

info
Versus Nifty 50
1 w
+2.38%
vs
+2%
1 mth
+1.86%
vs
+2.83%
3 mth
+2.59%
vs
+5.36%
6 mth
+0.33%
vs
-0.29%
1 yr
+24.04%
vs
+8.6%
3 yr
+143.46%
vs
+41.68%
5 yr
+174.22%
vs
+165.76%
Torrent Pharmaceuticals Ltd Top mutual funds holding
arrow
Torrent Pharmaceuticals Limited has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.
personal

Grow your wealth with more research recommendations

+91